Vanda Pharmaceuticals
VNDA
#7543
Rank
NZ$0.69 B
Marketcap
NZ$11.71
Share price
-2.70%
Change (1 day)
41.27%
Change (1 year)

EPS for Vanda Pharmaceuticals (VNDA)

EPS in 2025 (TTM): NZ-$2.43

According to Vanda Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$2.43. In 2024 the company made an earnings per share (EPS) of NZ-$0.55 a decrease over its 2023 EPS that were of NZ$0.08967.

EPS history for Vanda Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$2.43344.39%
2024NZ-$0.55-710.9%
2023NZ$0.08967-56.35%
2022NZ$0.21-80%
2021NZ$1.03
2019NZ$3.71334%
2018NZ$0.86-247.06%
2017NZ-$0.58-19.05%
2016NZ-$0.72-55.32%
2015NZ-$1.61-347.37%
2014NZ$0.65-156.72%
2013NZ-$1.15-31.63%
2012NZ-$1.68

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$12.60-618.31%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
NZ$35.12-1,544.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$17.87-835.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$5.08-309.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.94-221.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
NZ-$7.51 209.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$13.00-634.77%๐Ÿ‡บ๐Ÿ‡ธ USA